en

PRODUCT DETAIL

Moxifloxacin Kabi 400 mg/250 ml infúzny roztok

Code 9822A
MA number 42/0150/14-S
Product Form: sol inf 40x250 ml/400 mg (fľ.PE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA14 Moxifloxacin
Shelf life: 36
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.04.2014
Pediatric contraindication: Yes
SPC: SPC_Moxifloxacin Kabi 400 mg_250ml sol inf_04.2021.pdf  
PIL: PIL_Moxifloxacin Kabi 400 mg_250 ml sol inf fľaša_03.2024.pdf  
PIL: PIL_Moxifloxacin Kabi 400 mg_250 ml sol inf vak_03.2024.pdf  
Safety feature Yes
Data update: 09.09.2019
eu-flag.png sk-flag.png